Acarix AB (FRA:7AC) Cyclically Adjusted Book per Share: €0.07 (As of Mar. 2026)


FRA:7AC Acarix AB FRA:7AC
44 GF Score
Price €0.02
GF Value €0.01
! 1 Warning Sign
View Full Analysis

What is Acarix AB Cyclically Adjusted Book per Share?

Acarix AB FRA:7AC -1.28% 44 Cyclically Adjusted Book per Share is €0.07 as of Mar. 2026. GuruFocus rates FRA:7AC with a GF Score™ of 44/100 and a GF Value™ of €0.01. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Acarix AB's adjusted book value per share for the three months ended in Mar. 2026 was €0.003. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.07 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-02), Acarix AB's current stock price is €0.0154. Acarix AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €0.07. Acarix AB's Cyclically Adjusted PB Ratio of today is 0.22.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Acarix AB was 0.36. The lowest was 0.21. And the median was 0.25.


Acarix AB  (FRA:7AC) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Acarix AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0154/0.07
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Acarix AB was 0.36. The lowest was 0.21. And the median was 0.25.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Acarix AB Cyclically Adjusted Book per Share Related Terms


Acarix AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Acarix AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acarix AB Cyclically Adjusted Book per Share Chart

Acarix AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.07

Acarix AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.08 0.09 0.07 0.07

FRA:7AC vs ABT, SYK, MDT: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Acarix AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acarix AB Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acarix AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Acarix AB's Cyclically Adjusted PB Ratio falls into.


FRA:7AC
44GF Score
Acarix AB FRA:7AC
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acarix AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Acarix AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.003/133.3862*133.3862
=0.003

Current CPI (Mar. 2026) = 133.3862.

Acarix AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 101.019 0.000
201609 0.026 101.138 0.034
201612 0.315 102.022 0.412
201703 0.315 102.022 0.412
201706 0.297 102.752 0.386
201709 0.290 103.279 0.375
201712 0.256 103.793 0.329
201803 0.237 103.962 0.304
201806 0.217 104.875 0.276
201809 0.189 105.679 0.239
201812 0.168 105.912 0.212
201903 0.141 105.886 0.178
201906 0.118 106.742 0.147
201909 0.097 107.214 0.121
201912 0.095 107.766 0.118
202003 0.081 106.563 0.101
202006 0.069 107.498 0.086
202009 0.134 107.635 0.166
202012 0.044 108.296 0.054
202103 0.038 108.360 0.047
202106 0.031 108.928 0.038
202109 0.025 110.338 0.030
202112 0.032 112.486 0.038
202203 0.027 114.825 0.031
202206 0.021 118.384 0.024
202209 0.015 122.296 0.016
202212 0.015 126.365 0.016
202303 0.008 127.042 0.008
202306 0.008 129.407 0.008
202309 0.005 130.224 0.005
202312 0.006 131.912 0.006
202403 0.009 132.205 0.009
202406 0.008 132.716 0.008
202409 0.005 132.304 0.005
202412 0.006 132.987 0.006
202503 0.005 132.825 0.005
202506 0.004 133.699 0.004
202509 0.003 133.482 0.003
202512 0.003 133.386 0.003
202603 0.003 133.386 0.003

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.07 mean?
Acarix AB (FRA:7AC) has a Cyclically Adjusted Book per Share of €0.07 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Acarix AB and its competitors.
Is Acarix AB's Cyclically Adjusted Book per Share too high?
Acarix AB's current Cyclically Adjusted Book per Share is €0.07. Overall, Acarix AB has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Acarix AB's Cyclically Adjusted Book per Share compare to ABT and SYK?
Acarix AB's Cyclically Adjusted Book per Share of €0.07 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Acarix AB and its competitors. Acarix AB's current Cyclically Adjusted Book per Share is €0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acarix AB stock overvalued right now?
Acarix AB (FRA:7AC) has a current Cyclically Adjusted Book per Share of €0.07. The stock's GF Value™ is €0.01, compared to a current price of €0.02 — trading 54% above its estimated fair value. The current Cyclically Adjusted Book per Share is €0.07. Acarix AB's overall GF Score™ is 44/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Acarix AB (FRA:7AC), the current Cyclically Adjusted Book per Share is €0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acarix AB (FRA:7AC) Overvalued in 2026?

Based on GuruFocus' analysis, Acarix AB stock appears to be overvalued. The current stock price of €0.02 is trading 54% above its estimated GF Value™ of €0.01.

Key valuation signals for FRA:7AC:

  • Cyclically Adjusted Book per Share: €0.07
  • GF Value™: €0.01 vs. price of €0.02 (54% above fair value)
  • GF Score™: 44/100 with 1 warning sign

No single metric tells the full story. See the FRA:7AC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Acarix AB Business Description

Other Exchanges ACIXF:USAACARIX:Sweden
Address Hyllie Boulevard 34, Regus Malmo, Malmo, SWE, 215 32
Acarix AB is a Swedish medical technology company that develops solutions for rapid AI-based exclusion of coronary artery disease (CAD). Its CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. Acarix recommends the CADScor System as a first-line diagnostic tool that uses sensitive acoustics and computational processing to analyze coronary blood flow to rule out coronary artery disease (CAD), with a majority certainty at the point of care. Geographically, the company generates maximum revenue from the United States, and the rest from Germany, Sweden, Iraq, and other regions.
44GF Score

Get the complete analysis for FRA:7AC

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€0.01
GF Value